JASPER THERAPEUTICS, INC. Tax Withholding Paid on Stock Awards
JASPER THERAPEUTICS, INC. (JSPR) reported Tax Withholding Paid on Stock Awards of $960.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2025-02-28
- JASPER THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-12-31 was $299.00K.
- JASPER THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-09-30 was $0.00.
- JASPER THERAPEUTICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $960.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2023-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $299.00K derived: sum of 2 quarters · filed 2025-02-28 | $960.00K 10-K · filed 2025-02-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $661.00K 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $661.00K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |